Vitamin D has attracted enormous interest in recent years. Supporters have described it as a cure-all—capable of boosting heart health, lifespan, immune function, and more. But is it really the magic bullet it has been made out to be?
A leading scientific body has now significantly revised what was thought to be known about vitamin D. This article breaks down the latest research, flags some key cautions, and unpacks the updated recommendations for vitamin D supplementation—including why the current evidence points toward lower doses than many popular sources recommend, and why certain specific groups have genuinely different needs from the general population.
Table of Contents
The Hype
Vitamin D was discovered in the early 1900s by researchers working out how to cure rickets—a common bone disease seen in children. They found that vitamin D plays an essential role in forming and maintaining healthy bones.
But gradually, the understanding of vitamin D's role expanded. It isn't just important for bone health. It's also a key regulator of processes related to immune function, muscles, cell growth, and glucose metabolism. Most tissues in the body respond to vitamin D in some way.
This naturally led to interest in how vitamin D might be related to diseases beyond rickets. Once researchers started looking, they found associations everywhere. The early evidence appeared in observational studies—studies that watch people in the real world to see how particular metrics, like blood levels of vitamin D, correlate with health outcomes. The results showed an association between low vitamin D and cancer, infectious diseases, autoimmune conditions, diabetes, and heart disease [1]. These findings attracted enormous scientific and media attention, and it was not difficult to see why: if low vitamin D was associated with so many serious conditions, surely supplementing would offer broad protection.
What's more, researchers began sounding the alarm that a huge number of people were deficient in this key vitamin. A 2006 article summarised the evidence: more than a third of healthy young adults had low vitamin D levels, and for those seeking medical care, the number jumped to 57% [2].
A much more recent study estimates around 40% of Europeans are deficient [3].
Why so much deficiency? There's a straightforward narrative: vitamin D deficiency is a problem of the modern world. When people spent most of their time outdoors, it wasn't an issue—because the body synthesises vitamin D when skin is exposed to UV-B radiation from sunlight. The synthesis occurs in the skin, where cholesterol is converted to pre-vitamin D3 and then activated further in the liver and kidneys. But as more of daily life moved indoors, vitamin D levels suffered [4].
The issue seemed serious enough that some researchers used the word "pandemic" to describe vitamin D deficiency [5]. A group of experts commenting in 2016 called vitamin D deficiency in Europe a cause for concern and urged action [6].
In that context, a prestigious international organisation—the Endocrine Society—published guidelines around vitamin D. Those guidelines included three important points.
First, they established optimal levels for vitamin D in the blood. They defined deficiency as below 20 ng/mL, and insufficiency (a milder lack) as below 30 ng/mL [7].
Second, they made supplementation suggestions. Adults up to 50 years should generally get at least 600 international units (IU) of vitamin D a day; above 70, they counselled upping that to 800 IU. But they noted more might be helpful—to hit a target of 30 ng/mL, adults might need up to 2,000 IU daily [8].
Finally, they advocated for broader testing of vitamin D levels, recommending testing for those "at risk for deficiency" [9]—a group the guidelines acknowledged could include somewhere between 20 and 100% of the elderly, children, and young and middle-aged adults alike [9]. In fairness, the guidelines specifically called for screening in a much narrower range of clinical cases. But the logic of their position implied a potential benefit for fairly broad testing.
Those recommendations had a profound impact. Assessment in the U.S. found vitamin D supplement use jumped from 5% to 19% between 1999 and 2012, while overall supplement use remained stable [10]. That trend continues, with the global vitamin D market projected to reach one and a half billion dollars by 2034 [11].
Back to Earth
There's just one problem. Much of this popular picture about vitamin D now looks wrong. The Endocrine Society itself has made some major revisions.
The initial assumption was that low vitamin D played a causal role in health problems like cancer—meaning supplementation could help avoid these problems. But this runs headlong into a key limitation of observational studies: correlation isn't the same thing as causation.
Everyone knows grey hair is associated with getting older. But that doesn't mean grey hair causes ageing, and dyeing one's hair won't reverse it. The same logic applies to vitamin D. Does deficiency cause ill health, or does it merely correlate with it?
Consider the example of older adults who live in care homes. They spend the majority of their time indoors—and as a result, have low vitamin D. In contrast, healthier older adults who don't need residential care spend more time outside, and their vitamin D levels tend to be higher. In this scenario, low vitamin D levels correlate with poor health, but they clearly aren't causing it.
This is why ideas from observational studies need to be tested with controlled trials. A randomised controlled trial assigns participants to receive either the intervention (in this case, vitamin D supplements) or a placebo, and then tracks outcomes over time. This design controls for confounding variables and allows researchers to establish whether a relationship is causal rather than merely correlational. Researchers have now run many such trials specifically to test the benefits of vitamin D supplementation. Here's what they've found.
Heart health and cancer: The large VITAL trial examined the effects of daily vitamin D supplementation over 5 years in a group of 25,000 older adults, tracking heart attack rates. The conclusion? Vitamin D supplements did not reduce the rate of heart attacks, and did not bring down cancer rates either [12].
A separate study published in 2025 reinforces the cancer finding. Based on a trial of over 20,000 adults who took vitamin D supplements for up to 5 years, researchers found cancer rates for the vitamin D group were the same as in the control group [13].
Mental health and depression: Some research has linked low vitamin D with mood disorders and cognitive decline, with depression receiving particular attention. The results are mixed. A meta-analysis found vitamin D supplements improved symptoms for those with clinical indicators of depression [14], but did not help improve mood for those without clinically significant symptoms [15]. A subsequent large study in about 18,000 older adults, followed over 5 years, found the risk of developing clinically relevant depressive symptoms was no lower in those taking vitamin D—and their mood did not improve [16].
All-cause mortality: A large Cochrane review of 56 trials in 2014 found a small but statistically significant decrease in all-cause mortality with vitamin D supplementation—approximately 3% lower risk of death [17]. However, more recent evidence from large-scale trials paints a different picture: a meta-analysis completed in 2020 found vitamin D supplementation made no difference to all-cause mortality [18].
These studies, and others like them, cast serious doubt on the idea that broad populations need high-dose vitamin D to improve their health—and on the claim that there is a pandemic of deficiency. It is worth pausing to appreciate how significant this shift is. The RCT evidence now points in a consistent direction: for healthy adults without genuine deficiency, adding more vitamin D does not reduce the risk of major diseases, does not lower the risk of death, and does not substantially improve mood. The associations seen in observational studies appear, in many cases, to reflect confounding rather than causation.
That said, there are specific groups where vitamin D supplements do show clear benefit. These are reflected in the updated Endocrine Society guidelines [19].
Children (up to 18): The primary concern is rickets—a disease more common than many realise, particularly in areas with limited sunlight or low-vitamin-D diets. There is also evidence that adequate vitamin D levels help ward off respiratory infections, given vitamin D's role in immune response. The new guidelines recommend around 1,500 IU daily for this group [20].
Pregnancy: Supplementation during pregnancy can lower the risk of preeclampsia and preterm birth, and may improve newborn health. The guidelines recommend doses around 3,000 IU daily during pregnancy [21].
Those at high risk of progressing to diabetes: Vitamin D may play a preventative role in prediabetes—a condition where blood sugar is elevated but not yet high enough to be classified as type 2 diabetes. Studies suggest an average dose of about 3,500 IU daily may provide additional benefit in delaying or preventing progression [22].
Adults 75 years and older: As people age, skin becomes less efficient at producing vitamin D from sunlight, and the kidneys—which convert vitamin D to its active form—also slow down. Evidence indicates the risk of death decreases with vitamin D supplementation in this age group [23], which is why the guidelines specifically call out older adults as benefiting from regular supplementation.
But what about those not in these four groups? Here lies one of the most significant revisions from the Endocrine Society's earlier position. In their updated recommendations, they acknowledge a fundamental problem: what constitutes an "optimal" level of vitamin D is not actually known [24]. This is not a minor technical detail—it was the absence of this answer that allowed earlier guidelines to set thresholds that now appear to have been premature. And the absence of agreed optimal levels led the Society to abandon the earlier thresholds for insufficiency and deficiency [25], and to advise against routine screening for vitamin D levels [26].
This creates an important logical question: if there is no agreed threshold for what counts as deficient, how can researchers claim there is a "pandemic" of low vitamin D levels? Without an agreed adequate level, the answer is: they can't. The earlier estimates that tens of millions of people were deficient were based on cut-off values that have now been retired. That doesn't mean vitamin D deficiency is not real, or that the genuinely deficient don't benefit from supplementation—it means the scale of the supposed problem was significantly overstated.
Drawing on the totality of the study evidence, a tentative conclusion emerges. The studies on depression, all-cause mortality, and rickets show that people who are genuinely low in vitamin D do benefit from supplementing. But the large-scale trials that looked at supplementation across the general population found no benefits. Taken together, these two findings suggest most people already have adequate levels of vitamin D.
The analogy is sleep: if someone is already getting enough, a bit more isn't likely to make them feel more rested. But if genuinely sleep-deprived, additional sleep can make a big difference. Similarly, people who are vitamin D deficient show clear benefits from supplementation; those with adequate levels appear to gain no additional advantage—which explains why population-wide trials don't show broad benefits.
The current evidence does not support the notion that a large portion of the general population is suffering from meaningfully low vitamin D levels. People who spend reasonable time outdoors, eat a varied diet, and are not in one of the four high-risk groups described above are likely obtaining sufficient vitamin D through natural routes. The widespread anxiety about vitamin D deficiency—and the accompanying boom in high-dose supplementation—appears to have outrun the evidence considerably.
What's more, evidence points to potential risks on the other side of the equation. With the recent enthusiasm for high-dose vitamin D supplements, there is a real chance of taking too much. This is not a theoretical concern—clinical trials have now demonstrated concrete harms at doses commonly promoted by supplement influencers.
Bone density risks at high doses: A 3-year clinical trial in Canada tested the impact of several daily doses of vitamin D: 400 IU, 4,000 IU, and 10,000 IU. The focus was on bone density. The results were striking. The higher doses didn't improve outcomes—they made them worse. Bone density in the wrist decreased by about 2.4% in the 4,000 IU group and 3.5% in the 10,000 IU group [27]. This relates to a known risk of excessive vitamin D: hypercalcemia, which can begin pulling calcium from bones rather than depositing it.
Muscle weakness: Emerging evidence shows high doses may weaken muscles. In one study of women with low vitamin D, those who took 2,800 IU daily for 3 months saw their handgrip strength fall by 9% and their leg strength by 13% [28].
Falls risk in older adults: High-dose vitamin D can paradoxically increase the risk of falls. One study divided women into groups receiving different daily doses (ranging from 400 IU to 4,800 IU, plus a placebo group). Moderate supplementation appeared beneficial, but very high doses were not—those receiving 1,600 and 3,200 IU daily fell the least [29]. Among women with a prior history of falls, high doses actually increased fall rates [30]. A further study found a similar result, with the highest vitamin D doses associated with increased fall risk [31].
Current Recommendations
When it comes to vitamin D supplementation, more is definitely not always better. This is perhaps the most counterintuitive finding to emerge from the recent evidence base. In popular health media, the tendency has been to assume that if a little vitamin D is good, more must be better. The clinical data tell a different story.
The four groups with specific indications have been described above, each with their own targeted dose. For everyone else, the latest Endocrine Society guidelines suggest following the recommended daily intake: 600 IU for younger adults, rising to 800 IU from age 50 and above [32]. Notably, that is less than the Endocrine Society's previous recommendation. After a further 13 years of data collection and human trials, the Society revised its guidance downward—a sharp contrast to what many health influencers promote: high doses, often without testing or any clear indication of deficiency.
Based on the best available evidence, a dose in the 600–800 IU range for the general population is sufficient to ensure people are not deficient in vitamin D while locking in the well-established benefits. Supplementation beyond that level, for most healthy adults, is not supported by the current evidence base. It is a significant observation that the Endocrine Society—the same body that previously promoted higher doses and broader screening—has now moved in the opposite direction after more than a decade of additional clinical data. That trajectory should give pause to anyone relying on influencer advice that still promotes 5,000 IU or higher for general populations.
From the MicroVitamin range
MicroVitamin includes Vitamin D3 at 1,000 IU per serving, using encapsulated AlgeD3™ (an algae-derived form) for shelf-life stability—formulated at a dose that sits within the evidence-based range described in the updated Endocrine Society guidelines. Learn more about MicroVitamin.
Reference List
1. https://academic.oup.com/jcem/article/109/8/1961/7686350
2. https://pubmed.ncbi.nlm.nih.gov/16529140/
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC7091696/
5. https://pmc.ncbi.nlm.nih.gov/articles/PMC5527850/
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC5527850/
7. https://academic.oup.com/jcem/article/96/7/1911/2833671
8. https://academic.oup.com/jcem/article/96/7/1911/2833671
9. https://academic.oup.com/jcem/article/96/7/1911/2833671
10. https://pmc.ncbi.nlm.nih.gov/articles/PMC5540241/
11. https://www.precedenceresearch.com/vitamin-d-market
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC7089819
13. https://pubmed.ncbi.nlm.nih.gov/40096917/
14. https://pmc.ncbi.nlm.nih.gov/articles/PMC4008710/
15. https://pmc.ncbi.nlm.nih.gov/articles/PMC4008710/
16. https://pubmed.ncbi.nlm.nih.gov/32749491
17. https://pubmed.ncbi.nlm.nih.gov/24414552
18. https://pubmed.ncbi.nlm.nih.gov/31215980/
19. https://academic.oup.com/jcem/article/109/8/1907/7685305
20. https://academic.oup.com/jcem/article/109/8/1907/7685305
21. https://academic.oup.com/jcem/article/109/8/1907/7685305
22. https://academic.oup.com/jcem/article/109/8/1907/7685305
23. https://academic.oup.com/jcem/article/109/8/1907/7685305
24. https://academic.oup.com/jcem/article/109/8/1907/7685305
25. https://academic.oup.com/jcem/article/109/8/1907/7685305
26. https://academic.oup.com/jcem/article/109/8/1907/7685305
27. https://pubmed.ncbi.nlm.nih.gov/31454046/
28. https://pubmed.ncbi.nlm.nih.gov/29931459/
29. https://www.sciencedirect.com/science/article/abs/pii/S0960076017300808
30. https://www.sciencedirect.com/science/article/abs/pii/S0960076017300808
31. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2478897
32. https://academic.oup.com/jcem/article/109/8/1907/7685305
Note: This article is for informational purposes and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your supplement routine.
